TP53 and cancer: Notably, cancer cell DNA content and nucleus size were markedly different in the TP53 mutant and wild-type groups, reflecting remarkable increases in the amounts of cells exhibiting polyploid and aneuploid DNA in the TP53 mutant group, which resulted in exacerbated genomic instability and a high degree of malignancy.